Personalized Medicine in Cardiovascular Patients: From Basic Concepts to the Clinical Challenges
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".
Deadline for manuscript submissions: closed (15 April 2023) | Viewed by 1355
Special Issue Editor
2. Institute of Clinical Medicine and Cardiovascular Research Institute, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan
Interests: cardiac arrhythmias; electrophysiology; biological pacemakers; artificial intelligence
Special Issue Information
Dear Colleagues,
The individual differences in the genome and the environment bring about variable risks with regard to disease onset, therapeutic response, and prognosis in patients with cardiovascular diseases.
We hope to elucidate the novel mechanisms and relevant biomarkers to identify the patients at risk for rapid disease progression or poor therapeutic response. Therefore, personalized designs could be made for the diagnosis and treatment of cardiovascular diseases.
Rapid progression in the areas of the genome, omics, images, and physiology real-time monitoring all give us the chance to identify new mechanisms or biomarkers to identify personal variation for personalized medicine. However, the integration of these big data and their correlation to clinical practice and outcomes remains challenging. A translational study to prove the clinical benefits is a critical step before the personalized strategy is used in guiding clinical practice.
We are soliciting and will publish papers related to new mechanisms and specific biomarkers, and which are suggestive of the translational potential or could identify patients at risk for disease onset, poor therapeutic response, or prognosis in cardiovascular diseases.
Dr. Yu-Feng Hu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized medicine
- personalized medicine
- cardiovascular diseases
- genome
- omics
- images
- physiology monitoring
- mechanisms
- biomarker
